Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study

BACKGROUND: Mandatory trial registration, and later results reporting, were proposed to mitigate selective clinical trial publication and outcome reporting. The Food and Drug Administration (FDA) Amendments Act (FDAAA) was enacted by Congress on September 27, 2007, requiring the registration of all...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Trials
Asıl Yazarlar: Zou, Constance X., Becker, Jessica E., Phillips, Adam T., Garritano, James M., Krumholz, Harlan M., Miller, Jennifer E., Ross, Joseph S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199729/
https://ncbi.nlm.nih.gov/pubmed/30352601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-018-2957-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller